Avantor Change in Accounts Payable 2018-2025 | AVTR
Avantor annual/quarterly change in accounts payable history and growth rate from 2018 to 2025. Change in accounts payable can be defined as the increase or decrease in trade payables for the given period.
- Avantor change in accounts payable for the quarter ending June 30, 2025 was $0.019B, a 58.39% decline year-over-year.
- Avantor change in accounts payable for the twelve months ending June 30, 2025 was $0.129B, a 155.26% decline year-over-year.
- Avantor annual change in accounts payable for 2024 was $0.06B, a 142.69% decline from 2023.
- Avantor annual change in accounts payable for 2023 was $-0.14B, a 994.87% decline from 2022.
- Avantor annual change in accounts payable for 2022 was $0.016B, a 75.96% decline from 2021.
| Avantor Annual Change in Accounts Payable (Millions of US $) |
|
|---|---|
| 2024 | $60 |
| 2023 | $-140 |
| 2022 | $16 |
| 2021 | $65 |
| 2020 | $111 |
| 2019 | $-2 |
| 2018 | $34 |
| 2017 | $32 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $9.006B | $6.784B |
| Avantor Inc. is a provider of critical products and services primarily to biopharma, healthcare, education & government, advanced technologies & applied materials industries. Avantor Inc. is based in Radnor, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $148.745B | 27.59 |
| CVS Health (CVS) | United States | $90.318B | 11.23 |
| Elevance Health (ELV) | United States | $70.706B | 9.51 |
| Cencora (COR) | United States | $55.895B | 18.61 |
| DiDi Global (DIDIY) | China | $26.780B | 28.45 |
| Labcorp Holdings (LH) | United States | $22.945B | 18.24 |
| Natera (NTRA) | United States | $22.299B | 0.00 |
| BioMerieux (BMXMF) | France | $17.423B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.987B | 0.00 |
| ICON (ICLR) | Ireland | $13.870B | 13.35 |
| Medpace Holdings (MEDP) | United States | $13.114B | 34.71 |
| CochLear (CHEOY) | Australia | $12.814B | 0.00 |
| Solventum (SOLV) | United States | $12.614B | 13.01 |
| Viatris (VTRS) | United States | $12.300B | 4.38 |
| Caris Life Sciences,�Inc (CAI) | United States | $10.822B | 0.00 |
| Revvity (RVTY) | United States | $10.695B | 18.84 |
| Charles River Laboratories (CRL) | United States | $8.077B | 15.32 |
| Sonic Healthcare (SKHHY) | Australia | $7.700B | 0.00 |
| HealthEquity (HQY) | United States | $7.560B | 33.11 |
| Bausch + Lomb (BLCO) | Canada | $5.143B | 34.60 |
| Sotera Health (SHC) | United States | $4.656B | 26.02 |
| BrightSpring Health Services (BTSG) | United States | $4.266B | 32.54 |
| Amplifon S.p.A (AMFPF) | Italy | $3.937B | 21.83 |
| GeneDx Holdings (WGS) | United States | $3.501B | 80.18 |
| KindlyMD (NAKA) | United States | $3.449B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $3.085B | 0.00 |
| Concentras Parent (CON) | United States | $3.002B | 19.04 |
| Surgery Partners (SGRY) | United States | $2.954B | 37.16 |
| Organon (OGN) | United States | $2.355B | 2.57 |
| Premier (PINC) | United States | $2.116B | 19.62 |
| Progyny (PGNY) | United States | $1.990B | 42.07 |
| Ardent Health (ARDT) | United States | $1.816B | 7.01 |
| PACS (PACS) | United States | $1.797B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.486B | 9.92 |
| GoodRx Holdings (GDRX) | United States | $1.477B | 25.00 |
| Teladoc Health (TDOC) | United States | $1.355B | 0.00 |
| Omada Health (OMDA) | $1.209B | 0.00 | |
| Establishment Labs Holdings (ESTA) | $1.178B | 0.00 | |
| Ryman Healthcare (RYHTY) | New Zealand | $0.962B | 0.00 |
| Embecta (EMBC) | United States | $0.834B | 4.88 |
| AMN Healthcare Services Inc (AMN) | United States | $0.793B | 9.81 |
| CareDx (CDNA) | United States | $0.679B | 12.50 |
| Performant Healthcare (PHLT) | United States | $0.600B | 0.00 |
| Agilon Health (AGL) | United States | $0.572B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.519B | 89.00 |
| Nutex Health (NUTX) | United States | $0.497B | 7.53 |
| InnovAge Holding (INNV) | United States | $0.496B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.491B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.460B | 6.91 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.439B | 0.00 |
| SBC Medicals (SBC) | United States | $0.429B | 9.39 |
| Enhabit (EHAB) | United States | $0.409B | 26.90 |
| So-Young (SY) | China | $0.409B | 0.00 |
| Oncology Institute (TOI) | United States | $0.324B | 0.00 |
| LifeMD (LFMD) | United States | $0.294B | 0.00 |
| Beauty Health (SKIN) | United States | $0.266B | 0.00 |
| Shoulder Innovations (SI) | United States | $0.229B | 0.00 |
| DocGo (DCGO) | United States | $0.160B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.146B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.099B | 0.00 |
| Biodesix (BDSX) | United States | $0.072B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.059B | 0.00 |
| NeueHealth (NEUE) | United States | $0.059B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.039B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.025B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.022B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.010B | 0.00 | |
| ModivCare (MODV) | United States | $0.010B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| INVO Fertility (IVF) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |